The year Indian drug innovation bets started paying off
Indian drugmakers, known for their chemistry and prowess in making generics—cheaper copies of innovative drugs—for the world, have started pivoting towards innovation to stay competitive globally. Those who took the earliest, and riskiest, bets saw decisive gains this year.
Indian drugmakers, known for their chemistry and prowess in making generics—cheaper copies of innovative drugs—for the world, have started pivoting towards innovation to stay competitive globally. Those who took the earliest, and riskiest, bets saw decisive gains this year.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
